Australian researchers discover ‘genetic switch’ for breast cancer
- Missing AN-32: All leads have turned out to be bad, says Manohar Parrikar
- 7th Pay Commission: Govt issues notification, relief to lakhs of central govt employees
- Kashmir unrest: Barring Anantnag, curfew lifted from all parts; schools remain shut
- At least 19 killed in knife attack at facility for handicapped in Japan
- Delhi: Auto rickshaw, taxi strike hits commuters hard in the city
Australian researchers have discovered a "genetic switch" that can make breast cancer cells more responsive to different kinds of treatments. The switch allows scientists to change breast cancer cells and make them more responsive to treatments, such as anti-oestrogen therapies.
Researchers from the Garvan Institute of Medical Research in Sydney found that the molecule known as ELF5 can turn genes on or off, The Age reported. By manipulating the molecule, the breast cancer cell's sensitivity to anti-oestrogen drugs used to treat breast cancer can be increased.
"We've made a discovery that concerns the basic biology of breast cancer. ELF5 determines if cells will respond to oestrogen therapy or not," said Professor Chris Ormandy. Oestrogen plays a key role in breast cancers.
The finding establishes for the first time that there is a link between the molecule and breast cancer, the report said. Found in all breast cells, the molecule was discovered by Ormandy's team in 1999.
- Nativist sentiments and a growing tendency towards looking inwards imperil globalisation
- Poor infrastructure not outdated syllabi — is what ails Indian universities
- India will have to get its act together on urban water
- Qandeel Baloch’s murder: Men craft, interpret and adjudicate over family laws in the subcontinent
- BJP was not dependent on Dalits to win Gujarat. But the apathy may cost in other states
- Jayalalithaa and Mamata defend Mayawati, recast politics on gender lines